Latest Eczema news
Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
posted October 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema
posted October 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis
posted September 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Link Between n-3 LCPUFA, Eczema Varies by Maternal COX1 Genotype
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Lower Dietary Diversity in First Year Linked to Atopic Dermatitis 
Gene Mutation Identified That Increases Lung Cancer Risk 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population Related Articles
Distinct Skin Microbiome Features Emerge Before Atopic Disease Onset in Infants 
Risk for Herpes Zoster Elevated for Individuals With Atopic Dermatitis 
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis 
Review Shows Antihistamines Offer No Meaningful Benefit in Atopic Dermatitis Monthly Specialist Briefings
Stay Connected
